000 | 01495 a2200409 4500 | ||
---|---|---|---|
005 | 20250516235559.0 | ||
264 | 0 | _c20141217 | |
008 | 201412s 0 0 eng d | ||
022 | _a1546-170X | ||
024 | 7 |
_a10.1038/nm.3652 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOng, S Tiong | |
245 | 0 | 0 |
_aReply: the BIM deletion polymorphism cannot account for intrinsic TKI resistance of Chinese individuals with chronic myeloid leukemia. _h[electronic resource] |
260 |
_bNature medicine _cOct 2014 |
||
300 |
_a1090-1 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aApoptosis Regulatory Proteins _xgenetics |
650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xgenetics |
650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xgenetics |
650 | 0 | 4 |
_aLung Neoplasms _xgenetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMembrane Proteins _xgenetics |
650 | 0 | 4 |
_aPolymorphism, Genetic _xgenetics |
650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aProto-Oncogene Proteins _xgenetics |
650 | 0 | 4 |
_aSequence Deletion _xgenetics |
700 | 1 | _aChuah, Charles T H | |
700 | 1 | _aKo, Tun Kiat | |
700 | 1 | _aHillmer, Axel M | |
700 | 1 | _aLim, Wan-Teck | |
773 | 0 |
_tNature medicine _gvol. 20 _gno. 10 _gp. 1090-1 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/nm.3652 _zAvailable from publisher's website |
999 |
_c24260088 _d24260088 |